Role of Dadru Gajendra sinh lepa vs terbinafine ointment in the management of Tinea cruris
Phase 3
- Conditions
- Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2023/06/054377
- Lead Sponsor
- Dr Priyanka Pandurang Panchal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
i)Patients willing to participate in this trial through written informed consent
ii)Patients who are 18 years to 70 years of any sed
iii)Patients having specific symptoms of dadru kushtha
iv)Patients who have controlled DM
Exclusion Criteria
i)Person with age below 18 years and with age above 70 years
ii)Person having severe/chronic hepatic/renal diseases
iii)Person with chronic infectious disease such as active Tuberculosis,Hepatitis B or C,or HIV
iv)Chronicity more than 2 years
v)Pregnant women and lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief from subjective assessment criteria i.e clinical signs and symptoms of dadru kushta such as redness (raga),pustules (Pidaka), itching(kandu) ,number of mandals, size of mandalsTimepoint: Baseline,after 7 days for 21days
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil